Immunome Inc. (IMNM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Immunome Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$18.76
−0.05% today
Market cap
$2.2B
Overall quality
—
Kronos AI 30-day
+13.2%
8 of 8 simulated paths end higher
Immunome Inc. (IMNM) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.2B. It trades at $18.76, down 0.05% today. 12 analysts' average target of $35.33 implies +88.3% from today's price. Kronos AI's 30-day forecast is +13.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $35.33 |
| Low – high | $24.00 – $40.00 |
| Analysts | 12 |
| Upside to average | +88.3% |
Kronos AI 30-day forecast
| Expected close | $21.25 (+13.2%) |
| Likely range | +7.4% … +28.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.